Related Experiment Video
Updated: Aug 21, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Xiaoqinglong decoction attenuates allergic rhinitis comorbid with asthma via modulation of the ALOX15/GPX4 axis
Ruizhi Wang1,2,3, Zhenhao Xiao1,2,3, Yiwen Li1,2,3
1Department of Otolaryngology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Objective:
Xiaoqinglong decoction (XQLD) is a classical traditional Chinese medicine (TCM) formula for allergic rhinitis (AR) and asthma. However, its underlying therapeutic mechanisms in allergic rhinitis comorbid with asthma (ARCA) remain elusive. This study employed proteomics to investigate the therapeutic effects and molecular mechanisms of XQLD in ARCA, aiming to provide a scientific basis for clinical research.
Methods:
Forty BALB/c mice were randomly divided into four groups: control, model, dexamethasone-treated, and XQLD-treated. An ARCA model was established using ovalbumin (OVA) and aluminum hydroxide. Airway allergic symptoms, serum levels of OVA-sIgE, and histopathological changes in nasal and lung tissues were assessed. Flow cytometry was performed to analyze the proportions of Th1 (CD4+IFN-γ+) and Th2 (CD4+IL-5+) cells in lung and spleen tissues. Proteomic analysis was conducted to identify differentially expressed proteins, which were subsequently subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. The expression levels of anti-arachidonate 15-lipoxygenase (ALOX15) and anti-glutathione peroxidase 4 (GPX4) were validated using western blotting and immunofluorescence staining.
Results:
ARCA model mice exhibited increased airway allergic symptom score and serum OVA-sIgE levels, accompanied by marked inflammatory cell infiltration and goblet cell hyperplasia in nasal and lung tissues. A pronounced Th1/Th2 imbalance was observed, characterized by elevated frequencies of Th1 and Th2 cells and a decreased Th1/Th2 ratio. Additionally, ARCA model mice showed upregulated ALOX15 expression and downregulated GPX4 expression. Treatment with XQLD ameliorated these pathological and immunological abnormalities.
Conclusions:
XQLD alleviates allergic airway inflammation and tissue remodeling in ARCA, potentially by restoring the ALOX15/GPX4 axis-mediated equilibrium between lipid peroxidation and antioxidant defense systems.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: